Skip to main content

AC Meyer

First name:
AC
Last name:
Meyer
Meyer, A. C., Horton, D. B., Neugebauer, N. M., Wooters, T. E., Dwoskin, L. P., & Bardo, M. T. (2011). Tetrabenazine inhibition of monoamine uptake and methamphetamine behavioral effects: locomotor activity, drug discrimination and self-administration. Neuropharmacology, 61(4), 849-56. https://doi.org/10.1016/j.neuropharm.2011.05.033
Meyer, A. C., Rahman, S., Charnigo, R. J., Dwoskin, L. P., Crabbe, J. C., & Bardo, M. T. (2010). Genetics of novelty seeking, amphetamine self-administration and reinstatement using inbred rats. Genes, Brain, And Behavior, 9(7), 790-8. https://doi.org/10.1111/j.1601-183X.2010.00616.x
Beckmann, J. S., Meyer, A. C., & Bardo, M. T. (2013). Concurrent choice for social interaction and amphetamine using conditioned place preference in rats: effects of age and housing condition. Drug And Alcohol Dependence, 129(3), 240-6. https://doi.org/10.1016/j.drugalcdep.2013.02.024 (Original work published 2013)
Meyer, A. C., Neugebauer, N. M., Zheng, G., Crooks, P. A., Dwoskin, L. P., & Bardo, M. T. (2013). Effects of VMAT2 inhibitors lobeline and GZ-793A on methamphetamine-induced changes in dopamine release, metabolism and synthesis in vivo. Journal Of Neurochemistry, 127(2), 187-98. https://doi.org/10.1111/jnc.12373
Perry, J. L., Meyer, A. C., Gipson, C. D., Charnigo, R., & Bardo, M. T. (2014). Role of medial prefrontal and orbitofrontal monoamine transporters and receptors in performance in an adjusting delay discounting procedure. Brain Research, 1574, 26-36. https://doi.org/10.1016/j.brainres.2014.06.004 (Original work published 2014)
Meyer, A. C., & Bardo, M. T. (2015). Amphetamine self-administration and dopamine function: assessment of gene × environment interactions in Lewis and Fischer 344 rats. Psychopharmacology, 232(13), 2275-85. https://doi.org/10.1007/s00213-014-3854-1
Beckmann, J. S., Meyer, A. C., Pivavarchyk, M., Horton, D. B., Zheng, G., Smith, A. M., et al. (2015). r-bPiDI, an α6β2* Nicotinic Receptor Antagonist, Decreases Nicotine-Evoked Dopamine Release and Nicotine Reinforcement. Neurochemical Research, 40(10), 2121-30. https://doi.org/10.1007/s11064-015-1680-4
Meyer, A. C., Dua, T., Boscardin, W. J., Escarce, J. J., Saxena, S., & Birbeck, G. L. (2012). Critical determinants of the epilepsy treatment gap: a cross-national analysis in resource-limited settings. Epilepsia, 53(12), 2178-85. https://doi.org/10.1111/epi.12002
Meyer, A. C., Dua, T., Ma, J., Saxena, S., & Birbeck, G. (2010). Global disparities in the epilepsy treatment gap: a systematic review. Bulletin Of The World Health Organization, 88(4), 260-6. https://doi.org/10.2471/BLT.09.064147